News

BioRewards Plasma Services ("BioRewards"), a next-generation plasma collection company, has officially launched with the backing of Alpha-1 Plasma Holdings ("Alpha-1"), a premier investor in plasma ...
Morning! Today we start with some breaking newss: Novo Nordisk’s CEO is stepping down. We also discuss a new, tailored CRISPR treatment for an infant with a deadly disease, how Amgen owes Regeneron ...
DZ Bank has significantly reduced its holdings in Regeneron Pharmaceuticals, offloading 74.4% of its shares in Q4. Despite ...
Regeneron (REGN) wins $400M in damages as jury finds Amgen (AMGN) violated antitrust laws by promoting its heart drug Repatha ...
A federal jury found Amgen liable for violating antitrust and tort laws. Elsewhere, Allogene and Kyverna trimmed staff and ...
Acadia Pharmaceuticals Inc. today announced that the U.S. District Court for the District of Delaware ruled in favor of Acadia regarding its ?721 formulation patent for NUPLAZID® (pimavanserin), ...
Cencora is an established healthcare distributor, which can capture market demand, and is a proven dividend grower. Learn why ...
This was the stock's second consecutive day of gains.
Their noteworthy success ratio suggests that the firm does well for investors and that this fund may benefit from that. However, the process is limited by high costs across its parent firm's funds ...
A cheap snapshot of the large-growth market. Our research team assigns Silver ratings to strategies that they have a high conviction will outperform the relevant index, or most peers, over a ...
To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...
In 2024, Boeing checked the investors' interest in the assets of the Orca UAV submarine division and decided to keep the assets owned. Boeing is one of the world's largest manufacturers of aviation, ...